Caterina Bendotti
Overview
Explore the profile of Caterina Bendotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
2846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niccolai E, Di Gloria L, Trolese M, Fabbrizio P, Baldi S, Nannini G, et al.
Acta Neuropathol Commun
. 2025 Jan;
13(1):5.
PMID: 39794859
No abstract available.
2.
Fabbrizio P, Baindoor S, Margotta C, Su J, Morrissey E, Woods I, et al.
Brain Pathol
. 2024 Dec;
:e13328.
PMID: 39731449
Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease with no effective treatments, in part caused by variations in progression and the absence of biomarkers. Mice carrying the SOD1G93A transgene...
3.
Baindoor S, Gibriel H, Veno M, Su J, Morrissey E, Jirstrom E, et al.
Dis Model Mech
. 2024 Nov;
17(11).
PMID: 39552337
Transfer RNA-derived small RNAs (tsRNAs) - categorized as tRNA-derived fragments (tRFs), tRNA-derived stress-induced RNAs (tiRNAs) and internal tRF (itRF) - are small non-coding RNAs that participate in various cellular processes...
4.
Niccolai E, Di Gloria L, Trolese M, Fabbrizio P, Baldi S, Nannini G, et al.
Acta Neuropathol Commun
. 2024 Nov;
12(1):174.
PMID: 39506789
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder characterized by the progressive loss of motor neurons, with genetic and environmental factors contributing to its complex pathogenesis. Dysregulated immune responses...
5.
Pupillo E, Bianchi E, Bonetto V, Pasetto L, Bendotti C, Paganoni S, et al.
Brain Behav Immun
. 2024 Aug;
122:456-462.
PMID: 39182589
Background: Positive effects of RNS60 on respiratory and bulbar function were observed in a phase 2 randomized, placebo-controlled trial in people with amyotrophic lateral sclerosis (ALS). Objective: to investigate the...
6.
Yip P, Pizzasegola C, Gladman S, Biggio M, Marino M, Jayasinghe M, et al.
PLoS One
. 2024 Jul;
19(7):e0307246.
PMID: 38990842
[This corrects the article DOI: 10.1371/journal.pone.0061626.].
7.
Tortarolo M, Re Cecconi A, Camporeale L, Margotta C, Nardo G, Pasetto L, et al.
Neurobiol Dis
. 2024 Jun;
199:106576.
PMID: 38914173
Variability in disease onset and progression is a hallmark of amyotrophic lateral sclerosis (ALS), both in sporadic and genetic forms. Recently, we found that SOD1-G93A transgenic mice expressing the same...
8.
Golia M, Frigerio R, Pucci S, Sironi F, Margotta C, Pasetto L, et al.
Exp Neurol
. 2024 Feb;
374:114716.
PMID: 38331161
SOD1 gene is associated with progressive motor neuron degeneration in the familiar forms of amyotrophic lateral sclerosis. Although studies on mutant human SOD1 transgenic rodent models have provided important insights...
9.
Nutma E, Fancy N, Weinert M, Tsartsalis S, Marzin M, Muirhead R, et al.
Nat Commun
. 2023 Aug;
14(1):5247.
PMID: 37640701
Microglial activation plays central roles in neuroinflammatory and neurodegenerative diseases. Positron emission tomography (PET) targeting 18 kDa Translocator Protein (TSPO) is widely used for localising inflammation in vivo, but its...
10.
Margotta C, Fabbrizio P, Ceccanti M, Cambieri C, Rufolo G, DAgostino J, et al.
Inflamm Regen
. 2023 Apr;
43(1):25.
PMID: 37072876
No abstract available.